Home | Jerini Cares Login | Contact Us | Jerini Websites   
JERINICares About HAE Contact Us Blank - do not delete

This site is no longer operational contact Shire Pharmaceuticals for further information.

At Jerini US, we are driven by a commitment to improving the quality of life for people having rare diseases, with a primarily focus on HAE (hereditary angioedema).

We are proud to introduce JeriniCaresSM, a program that provides HAE patients and health care professionals with information on coverage, reimbursement and claims processing requirements for HAE medications.

REGISTER NOW to gain access to areas of the website containing additional information on hereditary angioedema in the HAE Information Center.

Sign-up to receive personalized information and/or assistance regarding:
      • Reimbursement assistance for HAE patients and support for health care offices
      • Possibly reducing the cost of current HAE therapy
      • HAE related disease information, when available
      • Potential Jerini US sponsored clinical trials
      • Jerini US specific marketing and/or product information, when available

5 Aug 2008
JeriniCares Program Launched
JeriniCares Program Launched Morristown, NJ, August 5th, 2008 – Jerini US announced today that the company has launched its JeriniCares initiative to help patients with the treatment of acute at... View Release

Health Care Professionals

Get Help With HAE

  • Third-party coverage
  • Product specific coverage
  • Therapy restrictions / limitations
  • Information on registering interest 
    in potential Jerini US sponsored
    clinical trials
  • Prior Authorization / Statement
    of Medical Necessity (SMN)
  • Insurance forms
  • Insurance coding
  • Appeals of denied claims

Log In to Jerini Cares
Login to the JeriniCares Information Center.


© 2024 by Jerini USA. All rights reserved. Web Design by The Birchwood Group - CMS Powered by Update On the Net.